Clinical characteristics of immune checkpoint inhibitor-related pancreatic injury with pancreatitis in patients with advanced malignancies
ICI-PI with pancreatitis is rare but has become more prevalent with the increasing use of ICIs. Future prospective multicenter studies are needed to confirm these findings and develop standardized diagnostic and treatment protocols.
Authors
- Takafumi Yamamoto (ORCID: https://orcid.org/0000-0002-9904-1894)
- Makoto Ishii (ORCID: https://orcid.org/0000-0003-4396-1664)
- Kazuyuki Mizuno (ORCID: https://orcid.org/0000-0001-8059-8433)
- Hiroki Kawashima (ORCID: https://orcid.org/0000-0002-3720-781X)
- Takanori Ito (ORCID: https://orcid.org/0000-0002-2594-0854)
- Shusuke Akamatsu (ORCID: https://orcid.org/0000-0002-1394-7506)
- Takuya Ishikawa (ORCID: https://orcid.org/0000-0001-5814-3555)
- Takaya Suzuki
- Yuichi Ando (ORCID: https://orcid.org/0000-0002-6849-2297)
- Takashi Honda
Institutions
- Nagoya University Hospital (JP)
- Nagoya University (JP)
Publication Details
- Journal
- Digestive and Liver Disease
- Published
- 2025-03-29
- DOI
- https://doi.org/10.1016/j.dld.2025.02.027
- Citations
- 7
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 7.32
Funders
- Japan Society for the Promotion of Science